Polymarket Pursues $400 Million Funding at $15 Billion Valuation
Polymarket is reportedly negotiating to secure $400 million in funding, aiming to bolster its market presence with a valuation set at $15 billion.
Latest Companies stories from Business & Industry.
Polymarket is reportedly negotiating to secure $400 million in funding, aiming to bolster its market presence with a valuation set at $15 billion.
As Google prepares to release its earnings, investors are increasingly focused on broader indicators that may shape the company's future.
As Jersey Mike's prepares for its initial public offering, we examine the potential implications and concerns surrounding this move.
The acquisition of Kelonia Therapeutics by Eli Lilly for $3.25 billion marks a significant turn for the struggling biotech firm, which faced numerous challenges.
Tesla has announced a rise in electric vehicle sales, yet the company is grappling with negative cash flows, raising questions about its financial health.
The unexpected exit of Fermi's CEO raises questions about the company's future and has left investors feeling uneasy about its direction.
Polestar's latest financial results indicate a troubling trend, with net losses widening even as revenue increases, raising questions about the sustainability of its growth.
Billionaire investor Brad Jacobs is pursuing a significant acquisition of TopBuild by QXO, potentially reshaping the US building products landscape.
TotalEnergies is forecasting strong earnings for the first quarter, a projection that appears to be influenced by the ongoing conflict between the US and Iran.
An overview of Sigma Lithium's recent financing achievements and production forecasts, highlighting its growth potential.
This overview discusses the Kemp-Kasten amendment, which restricts U.S. funding to organizations like UNFPA based on their involvement with coercive abortion or involuntary sterilization.
An overview of AngioDynamics, Inc.'s financial results for the third quarter of 2026, highlighting key performance metrics.
In a significant move to enhance its oncology pipeline, Gilead has announced the acquisition of Tubulis, a German biotech firm, for more than $3 billion.
Strategic angle: Shareholders approve the merger between OceanFirst and Flushing.
Strategic angle: Dodge CEO Matt McAlear said a sub-$30,000 performance car would make a lot of sense.
Strategic angle: Insights from Roundtable CEO on strategic direction and financial structure.
Strategic angle: ASML's financial outlook suggests significant revenue growth on the horizon.
Strategic angle: Goldman Sachs cautions tech workers facing layoffs about the challenges of job searching and potential earnings loss.
Strategic angle: PDD Holdings announces its financial results for 2025, revealing a significant revenue figure but a decline in net income.
Strategic angle: Jim Cramer highlights the leadership of Intel's CEO in a recent commentary.